Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
- Previous Close
26.00 - Open
26.06 - Bid 26.29 x --
- Ask 26.31 x --
- Day's Range
25.61 - 26.46 - 52 Week Range
19.37 - 30.49 - Volume
686,664 - Avg. Volume
1,121,233 - Market Cap (intraday)
6.539B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
50.60 - EPS (TTM)
0.52 - Earnings Date --
- Forward Dividend & Yield 0.17 (0.65%)
- Ex-Dividend Date Jun 1, 2023
- 1y Target Est
26.70
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide. It also provides starch sugars comprising allulose, maltitol, organic maltodextrin, allulose psicose, and isomaltulose, as well as allulose power and maltitol syrups. The company's products are used in food, medicine, health, and diary related products. It serves in the markets, including Africa, Asia, Europe, Australia, and the Americas. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. was founded in 2005 and is based in Yucheng, China.
www.sdblcy.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 605016.SS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 605016.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 605016.SS
Valuation Measures
Market Cap
6.54B
Enterprise Value
6.10B
Trailing P/E
50.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.57
Price/Book (mrq)
4.49
Enterprise Value/Revenue
7.39
Enterprise Value/EBITDA
29.67
Financial Highlights
Profitability and Income Statement
Profit Margin
22.23%
Return on Assets (ttm)
--
Return on Equity (ttm)
13.78%
Revenue (ttm)
868.26M
Net Income Avi to Common (ttm)
192.99M
Diluted EPS (ttm)
0.52
Balance Sheet and Cash Flow
Total Cash (mrq)
493.78M
Total Debt/Equity (mrq)
3.60%
Levered Free Cash Flow (ttm)
--
Research Analysis: 605016.SS
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 605016.SS
605016.SS does not have Company Insights